Ze-yang Ding
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 5
- Hepatology 11
- Liver physiology and pathology 6
- Co-authors
- Bixiang Zhang (41 shared papers)Huifang Liang (32 shared papers)Xiaoping Chen (27 shared papers)Ganxun Li (25 shared papers)Weixun Chen (9 shared papers)Zhao Xiang Huang (11 shared papers)Guan-nan Jin (20 shared papers)Peng Zhu (9 shared papers)
- Journals
- Aging (5 papers)Hepatology (4 papers)Medicine (3 papers)Frontiers in Immunology (3 papers)Advanced Science (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ze-yang Ding
87 papers receiving 2.2k citations
Ze-yang Ding's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 422
- Hepatology 183
- Oncology 370
- Biological Psychiatry 33
- Molecular Biology 792
Countries citing papers authored by Ze-yang Ding
This map shows the geographic impact of Ze-yang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze-yang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze-yang Ding more than expected).
Fields of papers citing papers by Ze-yang Ding
This network shows the impact of papers produced by Ze-yang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze-yang Ding. The network helps show where Ze-yang Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ze-yang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 113 | |
| 2 | 2014 | 97 | |
| 3 | 2021 | 78 | |
| 4 | 2015 | 77 | |
| 5 | 2022 | 73 | |
| 6 | 2020 | 64 | |
| 7 | 2020 | 61 | |
| 8 | 2018 | 60 | |
| 9 | 2013 | 60 | |
| 10 | 2023 | 60 | |
| 11 | 2019 | 59 | |
| 12 | 2020 | 58 | |
| 13 | 2023 | 57 | |
| 14 | Cancer stem cells and niches: challenges in immunotherapy resistance Hit paper breakdown → | 2025 | 55 |
| 15 | 2024 | 51 | |
| 16 | 2016 | 51 | |
| 17 | 2022 | 51 | |
| 18 | 2019 | 49 | |
| 19 | 2021 | 48 | |
| 20 | 2019 | 41 |
About Ze-yang Ding
Ze-yang Ding is a scholar working on Cancer Research, Hepatology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), TGF-β signaling in diseases (7 papers), Liver physiology and pathology (6 papers), Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), COVID-19 Clinical Research Studies (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (422 citations), Hepatology (183 citations), Oncology (370 citations), Biological Psychiatry (33 citations) and Molecular Biology (792 citations). Ze-yang Ding has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Bixiang Zhang, Huifang Liang, Xiaoping Chen, Ganxun Li, Weixun Chen, Zhao Xiang Huang, Guan-nan Jin, Peng Zhu, Jia Song and Wanguang Zhang. Their work appears in journals such as Aging, Hepatology, Medicine, Frontiers in Immunology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.